Brief: Erythech Pharma End-March Cash And Cash Equivalents Of EUR 30.5 Million

Phaxiam Therapeutics SA

09/05/2023 07:49

May 9 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * PROVIDES BUSINESS AND FINANCIAL UPDATE FOR THE FIRST
QUARTER OF
2023
    * CASH AND CASH EQUIVALENTS OF EUR 30.5MILLION
($33.7MILLION) AT
END OF MARCH 2023
    * ERYTECH AND PHERECYDES INTEND TO MERGE THEIR OPERATIONS
AND
RELOCATE ALL TEAMS TO ERYTECH'S PREMISES IN LYON
    * PROPOSED TRANSACTION IS EXPECTED TO CLOSE SHORTLY AFTER
APPROVAL
BY SHAREHOLDERS
    * PROJECT IS SUPPORTED BY BOARDS OF DIRECTORS AND MAJOR
SHAREHOLDERS OF ERYTECH AND PHERECYDES

Source text for Eikon:  ID:nGNE7zWxrF 
Further company coverage:  ERYP.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))